Loading News...
Back to Dashboard

Novanta Inc. (NOVT)

Real-time intraday values

Market Overview

From:
To:
NOVT Intraday
No data available
SymbolNOVT
IPO DateMar 24, 1999
CEOMr. Matthijs Glastra
Full Time Employees3k
SectorTechnology
IndustryScientific & Technical Instruments
CountryUnited States
ExchangeNasdaqGS
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Performance
PeriodReturn %Value Change
1 Day
-1.61%
-2.64 US$
5 Days
-2.06%
-3.40 US$
1 Month
+16.91%
+23.39 US$
6 Months
+34.78%
+41.73 US$

Analyzing Market with AI

Evaluating the last 30 days of history and fundamental metrics of NOVT...

Key Statistics
Market Cap
5.76B
P/E Ratio
115.52
Div Yield
N/A
52W High
$171.85
52W Low
$98.27

Analyst Consensus

ConsensusStrong Buy
Bullish3100.0%
Neutral00.0%
Bearish00.0%

52W Analyst Price Targets

Min Target
$170.00
Max Target
$173.00
Current$161.70
Avg Target$171.50

Analyst Recommendations

Target Price:$171.50($170.00 - $173.00)
FirmRatingTarget PriceUpside PotentialDate
BairdOutperform$173.00+6.99%5/13/2026
BairdOutperform$144.00-10.95%3/30/2026
Community Thoughts

Share your analysis and sentiment on NOVT

Join the community to share your analysis